Finally, we assessed the expression of ATF3-regulated genes in tumors with low levels of EZH2 (bottom 10%) and tumors with high levels of EZH2 (top 10%), in these 3 prostate cancer datasets (Fig 4F–4H). This evidence concerns the gene ATF3 and Familial prostate cancer.